Insider Trading History of Wan Mark A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Wan Mark A since 2011. The trader's CIK number is 1190472. At the time of the last reporting, Wan Mark A was the Director of Acelrx Pharmaceuticals Inc. (stock ticker symbol ACRX). Also see all insider trading activities at Acelrx Pharmaceuticals Inc.

Note that in the past WAN MARK A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Epocrates Inc (EPOC) by Wan Mark A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 EPOC 0 $0 292,116 $4,673,856 0 $0

Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Wan Mark A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 CNCE 207,000 $2,898,000 0 $0 0 $0

Yearly summary of insider trading at Acelrx Pharmaceuticals Inc (ACRX) by Wan Mark A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 ACRX 0 $0 1,000,000 $12,329,370 0 $0


Insider trading activities at 3 companies by Wan Mark A:

1. Epocrates Inc (EPOC)

2. Concert Pharmaceuticals, Inc. (CNCE)

3. Acelrx Pharmaceuticals Inc (ACRX)

Table 1. Insider trading of Epocrates Inc (EPOC) by Wan Mark A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-02-07 EPOC Sale 292,116 16.00 4,673,856

Table 2. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Wan Mark A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-02-19 CNCE Buy 103,500 14.00 1,449,000
2014-02-19 CNCE Buy 103,500 14.00 1,449,000

Table 3. Insider trading of Acelrx Pharmaceuticals Inc (ACRX) by Wan Mark A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-03-07 ACRX Sale 164,673 12.17 2,004,729
2014-03-10 ACRX Sale 835,327 12.36 10,324,641

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wan Mark A (Director of Acelrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.